Literature DB >> 17526821

Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?

Melania Manco1, José M Fernández-Real, Maria E Valera-Mora, Henri Déchaud, Giuseppe Nanni, Vincenzo Tondolo, Menotti Calvani, Marco Castagneto, Michel Pugeat, Geltrude Mingrone.   

Abstract

OBJECTIVE: Obesity, insulin resistance, and weight loss have been associated with changes in hypothalamic-pituitary-adrenal (HPA) axis. So far, no conclusive data relating to this association are available. In this study, we aim to investigate the effects of massive weight loss on cortisol suppressibility, cortisol-binding globulin (CBG), and free cortisol index (FCI) in formerly obese women. RESEARCH DESIGN AND METHODS: Ten glucose-normotolerant, fertile, obese women (BMI >40 kg/m2, aged 38.66 +/- 13.35 years) were studied before and 2 years after biliopancreatic diversion (BPD) when stable weight was achieved and were compared with age-matched healthy volunteers. Cortisol suppression was evaluated by a 4-mg intravenous dexamethasone suppression test (DEX-ST). FCI was calculated as the cortisol-to-CBG ratio. Insulin sensitivity was measured by an euglycemic-hyperinsulinemic clamp, and insulin secretion was measured by a C-peptide deconvolution method.
RESULTS: No difference was found in cortisol suppression after DEX-ST before or after weight loss. A decrease in ACTH was significantly greater in control subjects than in obese (P = 0.05) and postobese women (P < or = 0.01) as was the decrease in dehydroepiandrosterone (P < or = 0.05 and P < or = 0.01, respectively). CBG decreased from 51.50 +/- 12.76 to 34.33 +/- 7.24 mg/l (P < or = 0.01) following BPD. FCI increased from 11.15 +/- 2.85 to 18.16 +/- 6.82 (P < or = 0.05). Insulin secretion decreased (52.04 +/- 16.71 vs. 30.62 +/- 16.32 nmol/m(-2); P < or = 0.05), and insulin sensitivity increased by 163% (P < or = 0.0001). Serum CBG was related to BMI (r(0) = 0.708; P = 0.0001), body weight (r(0) = 0.643; P = 0.0001), body fat percent (r(0) = 0.462; P = 0.001), C-reactive protein (r(0) = 0.619; P = 0.004), and leptin (r(0) = 0.579; P = 0.007) and negatively to M value (r(0) = -0.603; P = 0.005).
CONCLUSIONS: After massive weight loss in morbidly obese subjects, an increase of free cortisol was associated with a simultaneous decrease in CBG levels, which might be an adaptive phenomenon relating to environmental changes. This topic, not addressed before, adds new insight into the complex mechanisms linking HPA activity to obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526821     DOI: 10.2337/dc06-1353

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

Review 1.  Change in Sexual Dysfunction Following Bariatric Surgery.

Authors:  Laura R Wingfield; Myutan Kulendran; Georgia Laws; Harvinder Chahal; Samantha Scholtz; Sanjay Purkayastha
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

2.  Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters.

Authors:  Draženka Janković; Peter Wolf; Christian-Heinz Anderwald; Yvonne Winhofer; Miriam Promintzer-Schifferl; Astrid Hofer; Felix Langer; Gerhard Prager; Bernhard Ludvik; Alois Gessl; Anton Luger; Michael Krebs
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

3.  Clinical manifestations of highly prevalent corticosteroid-binding globulin mutations in a village in southern Italy.

Authors:  Giovanni Cizza; Livia Bernardi; Nicoletta Smirne; Raffaele Maletta; Carmine Tomaino; Angela Costanzo; Maura Gallo; John G Lewis; Silvana Geracitano; Maria Beatrice Grasso; Giuseppe Potenza; Cosimo Monteleone; Giacomino Brancati; Jui T Ho; David J Torpy; Amalia C Bruni
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

4.  Pilot Study on Childhood Sexual Abuse, Diurnal Cortisol Secretion, and Weight Loss in Bariatric Surgery Patients.

Authors:  Polly A Hulme; Corrigan L McBride; Kevin A Kupzyk; Jeffrey A French
Journal:  J Child Sex Abus       Date:  2015

Review 5.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

6.  Sex defines the age dependence of endogenous ACTH-cortisol dose responsiveness.

Authors:  Daniel M Keenan; Ferdinand Roelfsema; Bernard J Carroll; Ali Iranmanesh; Johannes D Veldhuis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

7.  Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Ali Iranmanesh; Bernard J Carroll; Daniel M Keenan; Steven M Pincus
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

8.  Dairy food consumption and meal-induced cortisol response interacted to influence weight loss in overweight women undergoing a 12-week, meal-controlled, weight loss intervention.

Authors:  Megan G Witbracht; Marta Van Loan; Sean H Adams; Nancy L Keim; Kevin D Laugero
Journal:  J Nutr       Date:  2012-11-28       Impact factor: 4.798

9.  Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity.

Authors:  José Manuel Fernández-Real; Sergio Valdés; Melania Manco; Berta Chico; Patricia Botas; Arantza Campo; Roser Casamitjana; Elías Delgado; Javier Salvador; Gema Fruhbeck; Geltrude Mingrone; Wifredo Ricart
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 19.112

10.  Modulation in Wistar rats of blood corticosterone compartmentation by sex and a cafeteria diet.

Authors:  María del Mar Romero; Fredrik Holmgren-Holm; Maria del Mar Grasa; Montserrat Esteve; Xavier Remesar; José Antonio Fernández-López; Marià Alemany
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.